-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Head to Head Review: Science 37 (NASDAQ:SNCE) Versus Affinity Energy and Health (OTCMKTS:ALGXY)
Head to Head Review: Science 37 (NASDAQ:SNCE) Versus Affinity Energy and Health (OTCMKTS:ALGXY)
Science 37 (NASDAQ:SNCE – Get Rating) and Affinity Energy and Health (OTCMKTS:ALGXY – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, risk, earnings, analyst recommendations, dividends and institutional ownership.
Risk & Volatility
Science 37 has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Affinity Energy and Health has a beta of 135.11, suggesting that its share price is 13,411% more volatile than the S&P 500.
Get Science 37 alerts:Earnings and Valuation
This table compares Science 37 and Affinity Energy and Health's top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Science 37 | $59.60 million | 1.41 | -$94.33 million | ($0.50) | -1.44 |
Affinity Energy and Health | $2.05 million | N/A | -$6.08 million | N/A | N/A |
Insider & Institutional Ownership
58.6% of Science 37 shares are held by institutional investors. 4.4% of Science 37 shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Science 37 and Affinity Energy and Health's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Science 37 | -66.46% | -72.32% | -51.04% |
Affinity Energy and Health | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of current recommendations and price targets for Science 37 and Affinity Energy and Health, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Science 37 | 0 | 1 | 4 | 0 | 2.80 |
Affinity Energy and Health | 0 | 0 | 0 | 0 | N/A |
Science 37 currently has a consensus target price of $3.75, indicating a potential upside of 419.61%.
Summary
Affinity Energy and Health beats Science 37 on 5 of the 9 factors compared between the two stocks.
About Science 37
(Get Rating)
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
About Affinity Energy and Health
(Get Rating)
Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.
Receive News & Ratings for Science 37 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science 37 and related companies with MarketBeat.com's FREE daily email newsletter.
Science 37 (NASDAQ:SNCE – Get Rating) and Affinity Energy and Health (OTCMKTS:ALGXY – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, risk, earnings, analyst recommendations, dividends and institutional ownership.
科学37(纳斯达克:SNCE-GET评级)和亲和能源与健康(OTCMKTS:ALGXY-GET评级)都是医疗公司,但哪一项投资更具优势?我们将根据这两家公司的盈利能力、估值、风险、收益、分析师建议、股息和机构所有权等方面的实力进行比较。
Risk & Volatility
风险与波动性
Science 37 has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Affinity Energy and Health has a beta of 135.11, suggesting that its share price is 13,411% more volatile than the S&P 500.
Science 37的贝塔系数为1.27,这表明其股价的波动性比标准普尔500指数高27%。相比之下,Affity Energy and Health的贝塔系数为135.11,这表明其股价的波动性比标准普尔500指数高出13,411%。
Earnings and Valuation
收益和估值
This table compares Science 37 and Affinity Energy and Health's top-line revenue, earnings per share and valuation.
这张表格比较了Science 37和Affity Energy and Health的营收、每股收益和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Science 37 | $59.60 million | 1.41 | -$94.33 million | ($0.50) | -1.44 |
Affinity Energy and Health | $2.05 million | N/A | -$6.08 million | N/A | N/A |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
理科37 | 5,960万美元 | 1.41 | -9,433万元 | ($0.50) | -1.44 |
亲和力与健康 | 205万美元 | 不适用 | -608万元 | 不适用 | 不适用 |
Insider & Institutional Ownership
内部人与机构所有权
58.6% of Science 37 shares are held by institutional investors. 4.4% of Science 37 shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Science 37的58.6%股份由机构投资者持有。Science 37 4.4%的股份由内部人士持有。强大的机构持股表明,捐赠基金、大型基金经理和对冲基金相信,从长期来看,一只股票的表现将好于大盘。
Profitability
盈利能力
This table compares Science 37 and Affinity Energy and Health's net margins, return on equity and return on assets.
此表比较了Science 37和Affity Energy and Health的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Science 37 | -66.46% | -72.32% | -51.04% |
Affinity Energy and Health | N/A | N/A | N/A |
净利润率 | 股本回报率 | 资产回报率 | |
理科37 | -66.46% | -72.32% | -51.04% |
亲和力与健康 | 不适用 | 不适用 | 不适用 |
Analyst Ratings
分析师评级
This is a breakdown of current recommendations and price targets for Science 37 and Affinity Energy and Health, as reported by MarketBeat.com.
据MarketBeat.com报道,这是对科学37和亲和能源与健康的当前建议和目标价格的细分。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Science 37 | 0 | 1 | 4 | 0 | 2.80 |
Affinity Energy and Health | 0 | 0 | 0 | 0 | N/A |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
理科37 | 0 | 1 | 4 | 0 | 2.80 |
亲和力与健康 | 0 | 0 | 0 | 0 | 不适用 |
Science 37 currently has a consensus target price of $3.75, indicating a potential upside of 419.61%.
Science 37目前的共识目标价为3.75美元,表明潜在上行空间为419.61%。
Summary
摘要
Affinity Energy and Health beats Science 37 on 5 of the 9 factors compared between the two stocks.
在两只股票之间的9个因素中,有5个因素超过了科学37。
About Science 37
关于科学37
(Get Rating)
(获取评级)
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Science 37 Holdings,Inc.提供基于技术的解决方案,以实现灵活的临床试验和分散的方法。它的平台通过将包括患者和试验调查人员、护士、协调员和赞助商在内的各方聚集在一起,支持工作流程、集中证据生成和协调数据,从而实现临床研究的现代和数字化方法。它的平台还提供患者社区、远程医疗调查人员、移动护士、远程协调员和连接设备的专业网络,以协调灵活的临床试验;以及广泛的配置,以支持几乎任何临床研究阶段和任何适应症。此外,该公司还将其专有托管技术平台授权给各种生命科学机构。它为大中型制药公司、合同研究机构、学术机构和生物技术公司提供服务。Science 37 Holdings,Inc.成立于2014年,总部设在北卡罗来纳州的研究三角公园。
About Affinity Energy and Health
关于亲和力、能量与健康
(Get Rating)
(获取评级)
Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.
亲和能源和健康有限公司是一家以植物为基础的健康和福利公司,在澳大利亚、印度和美国运营。该公司致力于开发技术,生产商业数量的藻类和药用大麻,供藻类营养食品、动物饲料和水产养殖、药用大麻和生物燃料市场使用。该公司提供藻类饲料,一种以藻类为基础的水产饲料;以及以藻类为基础的生物燃料。亲和能源健康有限公司成立于2007年,总部设在澳大利亚苏比亚科。
Receive News & Ratings for Science 37 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science 37 and related companies with MarketBeat.com's FREE daily email newsletter.
接受《科学》杂志37期的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Science 37和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧